首页> 外文期刊>Gastrointestinal Endoscopy >Pharmacobezoar in a patient on an oral phosphate binder
【24h】

Pharmacobezoar in a patient on an oral phosphate binder

机译:口服磷酸盐粘合剂对患者的药代

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmacobezoars are a rare cause of intestinal obstruction.1 They are usually seen in the setting of altered mo-tility or anatomy of the GI tract, and certain medications including aluminum hydroxide, sucralfate, cholesty-ramine, nifedipine, and psyllium have been implicated in causing bezoars.2 They are difficult to diagnose reliably and usually require endoscopic or surgical management.3 Lanthanum carbonate (Fosrenol) is a chew-able oral phosphate binder used in patients with chronic kidney disease that has previously not been reported as a cause of a pharmacobezoar.
机译:药代动物是引起肠梗阻的罕见原因。1它们通常出现在胃肠道动力或解剖结构改变的环境中,并且某些药物包括氢氧化铝,硫糖铝,胆甾型胺,硝苯地平和车前草都涉及其中。 2难以可靠诊断,通常需要内窥镜或手术处理。3碳酸镧(Fosrenol)是一种可咀嚼的口服磷酸盐结合剂,用于慢性肾脏病患者,以前尚未被报道是引起这种疾病的原因。 Pharmaccobezoar。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号